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Abstract   
HAdV E1B-55K is a multifunctional regulator of productive viral replication and 
oncogenic transformation in non-permissive mammalian cells. These functions 
depend on E1B-55K’s posttranslational modification with the SUMO protein and its 
binding to HAdV E4orf6. Both early viral proteins recruit specific host factors to form 
an E3 Ubiquitin ligase complex that targets antiviral host substrates for proteasomal 
degradation. Recently, we reported that the PML-NB-associated factor Daxx 
represses efficient HAdV productive infection and is proteasomally degraded via a 
SUMO-E1B-55K-dependent, E4orf6-independent pathway, the details of which 
remained to be established.   
RNF4, a cellular SUMO-targeted Ubiquitin ligase (STUbL), induces ubiquitinylation 
of specific SUMOylated proteins and plays an essential role during DNA repair. 
Here, we show that E1B-55K recruits RNF4 to the insoluble nuclear matrix fraction 
of the infected cell to support RNF4/Daxx association, promoting Daxx PTM, and 
thus inhibiting this antiviral factor. Removing RNF4 from infected cells using RNAi 
resulted in blocking the proper establishment of viral replication centers and 
significantly diminished viral gene expression. These results provide a model for 
how HAdV antagonize the antiviral host responses by exploiting the functional 
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capacity of cellular STUbLs. Thus, RNF4 and its STUbL function represent a positive 
factor during lytic infection and a novel candidate for future therapeutic antiviral 






Importance   
Daxx is a PML-NB-associated transcription factor, which was recently shown to 
repress efficient HAdV productive infection. To counteract this antiviral 
measurement during infection, Daxx is degraded via a novel pathway including 
viral E1B-55K and host proteasomes. This virus-mediated degradation is 
independent of the classical HAdV E3 Ubiquitin ligase complex, which is essential 
during viral infection to target other host antiviral substrates. To maintain 
productive viral life cycle, HAdV E1B-55K early viral protein inhibits the 
chromatinremodeling factor Daxx in a SUMO-dependent manner. In addition viral 
E1B-55K protein recruits the STUbL RNF4 and sequesters it into the insoluble 
fraction of the infected cell. E1B-55K promotes complex formation between RNF4 
and E1B-55K targeted Daxx protein, supporting Daxx posttranslational modification 
prior to functional inhibition. Hence, RNF4 represents a novel host factor, which is 
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beneficial for HAdV gene expression by supporting Daxx counteraction. In this 
regard, RNF4 and other STUbL proteins might represent novel targets for 




PTM (posttranslational modification) of substrate proteins with Ubiquitin or SUMO 
(small Ubiquitin-like modifier) has been shown to regulate a diverse number of 
cellular processes, including proteasomal protein degradation, transcription factor 
activity, nuclear/cytoplasmic shuttling and DDR (DNA damage response) (1, 2). 
Intriguingly, several pathogens have evolved strategies to take advantage of the 
cellular Ubiquitin and SUMO machinery, either by modulating essential viral 
proteins or restricting cellular protein functions by PTM (3).    
HAdV (Human Adenoviruses) counteract cellular antiviral responses by producing 
the E1B-55K (early region 1B 55 kDa) protein that targets cellular proteins, such as 
Mre11, p53, DNA ligase IV, Tip60, Integrin α3, ATRX and SPOC1 for proteasomal 
degradation in cooperation with the E4orf6 (early region 4 open reading frame 6) 
protein. Together with a variety of host factors, such as Cullin5, Rbx1/RCO1/Hrt1, 
and Elongins B/C they assemble an SCF-like E3 Ubiquitin ligase complex (3, 4).   
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We reported previously, that the transcriptional repressor Daxx (death domain– 
associated protein) represents a negative regulator of HAd5 gene expression during 
productive infection (5-11). Daxx is mainly found in the nucleus, associated to 
PMLNBs (PML nuclear bodies), or at heterochromatin areas in a complex with ATRX 
(Xlinked -thalassaemia retardation syndrome protein) (2, 12). PML-NB association 
of Daxx was found to alleviate gene repression and activate apoptosis, while 
chromatin-bound Daxx acts in a transcriptionally repressive manner (13-15). Daxx 
association to either PML-NBs or chromatin depends on the status of the host cell 
and on the interaction of Daxx with other nuclear proteins (e.g. PML, ATRX), which 
can be regulated by PTM. Ishov and collegues also observed that cell cycle 
dependent phosphorylation regulates the exit of Daxx from PML-NBs prior to 
assembly to ATRX and chromatin-associated proteins like histone deacetylases, 
acetylated histone H4 and DEK at condensed chromatin regions (16-18).   
We demonstrated that the functional Daxx/ATRX chromatin-remodeling complexes 
in the nucleus of infected cells efficiently repress HAdV replication (19, 20). These 
data provide evidence that chromatin-modulating proteins play a major role during 
host cell intrinsic defense mechanism against HAdV. To oppose this repression, this 
virus antagonizes ATRX protein concentrations by proteasomal degradation via the 
E1B-55K/E4orf6 E3 Ubiquitin ligase complex during productive infection (21). In 
addition, we also discovered that E1B-55K alone inhibits the innate antiviral 
activities of Daxx by targeting this cellular protein for proteasomal degradation via 
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a so far unknown proteasome-dependent pathway, independent of E4orf6 (21). 
These findings illustrate the importance of E1B-55K in processes blocking innate 
antiviral  
activities.    
The cellular RNF4 (RING-finger protein 4) protein is a member of the STUbL  
(SUMO-targeted Ubiquitin ligases) protein family (2). STUbL proteins bind via 
SUMO-SIM interaction on SUMO-conjugated factors and thereby promote 
ubiquitinylation and proteasomal degradation of SUMO-modified target proteins. 
(22). RNF4 contains four functional SIM regions in the N-terminus and a 
RINGdomain at the C-terminal region, which is responsible for dimerization and 
activation of the ligase activity (23). Importantly, RNF4 mediates the 
ubiquitinylation, and thus proteasomal degradation of SUMO-modified PML, the 
scaffolding factor of PML-NBs (22, 24, 25) (26). Since PML-NBs are involved in virus 
infection, it is not surprising that RNF4 severely affects viral life cycles (22).  
Here, we show that RNF4 is sequestered into the insoluble nuclear matrix fraction of 
the host cell during HAdV infection. This relocalization is mediated by RNF4 
interaction with E1B-55K, independently of the SIM and ARM regions in the host 
protein. Furthermore, we provide evidence that E1B-55K connects RNF4 with the 
anti-HAdV transcription factor Daxx to simultaneously modulate Daxx PTM. This 
block of antiviral capacity is supported by the finding that HAdV gene expression is 
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reduced in RNF4 depleted cells. Taken together, our data demonstrate that E1B-55K 
together with RNF4 foster Daxx PTM most presumably prior to Daxx proteasomal 
degradation during HAdV infection, thus RNF4 expression is favorable for viral 
gene expression and replication.    
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Material and Methods   
Cell culture and generation of knock down cell lines.   
H1299 (ATCC Global Bioresource Center, No. CRL-5803) and HEK293 cells (ECACC 
European Collection of Authenticated Cell Cultures; Sigma Aldrich, No. 85120602-1VL) 
were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
calf serum, 100U of penicillin, 100µg of streptomycin per ml in a 5% CO2 atmosphere 
at 37°C.  To generate RNF4 knock down cell lines, H1299 cells were transduced with 
lentiviral vectors expressing shRNA targeted to the coding strand sequence 5’- 
CCGGACGTATATGTGACTACCCATACTCGAGTATGGGTAGTCACATATACG
T 
TTTTTG-3’ (Sigma Aldrich, mission RNA No. NM_002938.3 - 650s21c1). Knock 
down cell lines were selected and maintained in medium containing puromycin 
(2µg/ml). All cell lines are frequently tested for mycoplasma contamination.  
  
Plasmids and transient transfections.   
HAdV-C5 proteins examined in this study were expressed from their respective 
complementary DNAs under the control of CMV immediate-early promoter, 
derived from the pcDNA3 vector (Invitrogen) to express E1B-55K and accordingly 
E1B-55K-mutants (27). SFB (S tag, Flag epitope tag, and streptavidin-binding peptide 
tag)-derived wild type-, ΔARM, ΔSIM and double mutant Δ(ARM+SIM) plasmids 
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expressing RNF4 were kindly provided by Dr. Junjie Chen. RNF4 point mutations 
were introduced by site-directed mutagenesis using oligonucleotides shown in Table 
1. pcDNA3 derived pUbiquitin-His plasmid was kindly provided by Prof. Ron Hay. 
pDaxx-HA protein was expressed from pcDNA3 derived vector under CMV 
immediate-early promoter. shDaxx was targeted to the coding strand sequence 
5'GGAGTTGGATCTCTCAG AA-3` located at nt 626–643 in Daxx (28, 29). For 
transient transfections subconfluent cells were treated with a mixture of DNA and 
25kDa linear polyethylenimine (PEI) as described recently (21).  
  
Viruses. H5pg4100 served as the wild type (wt) virus (30). H5pm4149 carries stop 
codons in the E1B-55K open reading frames to prevent expression of E1B-55K (31) 
(32). Viruses were propagated and titrated in HEK293 cells. For this,  infected cells 
were harvested after 48h p.i. and lysed by three times of freeze and thaw and 
reinfected into HEK293 cells. Virus growth was determined by immunofluorescence 
staining of the adenoviral DNA binding protein E2A/DBP.  
  
Antibodies and protein analysis. Primary antibodies specific for viral proteins 
included E1B-55K mouse mAb 2A6 (33), E4orf6 mouse mAb RSA3 (34), L4-100K rat 
mAb 6B-10 (35), E2A/DBP mouse mAb B6-8 (36), E1A mouse mAb M73 (37), and 
HAdV-5 rabbit polyclonal serum L133 (38). Primary antibodies specific for cellular 
and ectopically expressed proteins included Daxx rabbit pAb 07-471 (Upstate), RNF4 
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mouse pAb A01 (Abnova), RNF4 mouse mAb (kindly provided by T. Urano), 
GAPDH Ab (sc-32233; Santa Cruz), H3 (Histon 3) Ab (1326-1; Epitomics), Mre11 
rabbit pAB pNB 100-142 (Novus Biologicals, Inc.), -Flag mouse mAb M2 
(SigmaAldrich, Inc.), -HA-tag rat mAb (Roche), -Ubiquitin mouse mAb (FK2; 
Affinity  
Research), -His-tag mouse mAb (Clontech), and ß-actin mouse mAb AC-15 
(SigmaAldrich, Inc.). Secondary Ab conjugated to horseradish peroxidase (HRP) for 
detection of proteins by immunoblotting were a -rabbit IgG, -mouse IgG, -mouse 
light chain IgG and -rat IgG (Jackson/Dianova). All protein extracts were prepared 
in RIPA lysis buffer as described recently (39). For immunoprecipitation, protein 
ASepharose beads (Sigma-Aldrich Inc.) coupled with 1µg of Ab for 1h at 4°C were 
used (3mg/immunprecipitation). The Ab-coupled protein A-Sepharose was added 
to pansorbin-Sepharose (50µl/lysate; Calbiochem) precleared extracts and rotated 
for 2h at 4°C. Proteins bound to the Ab-coupled protein A-Sepharose were 
precipitated by centrifugation, washed three times, boiled for 5min at 95°C in 2x 
Laemmli buffer, and analyzed by immunoblotting. Cell fractionation was performed 
based on a modified protocol described by Leppard et al (40), which we reported 
previously (41). For Ni-NTA pull down, cells were harvested 48h after treatment. 
20% of cells were pelleted to determine steady-state protein concentrations as 
    Müncheberg et al.   
  
 
  { PAGE   \* MERGEFORMAT }  
described above, whereas the remaining cells were resuspended in 5ml guanidinium 
hydrochloride (GuHCl) lysis buffer (0.1M Na2HPO4, 0.1M NaH2PO4, 10mM  
Tris/HCl pH 8.0, 20mM Imidazole and 5mM β-mercaptoethanol). Lysed cells in 
GuHCl were sonicated for 30s (40 pulses, output 0.6, 0.8 impulses/s) and 
supplemented with 25µl Ni-NTA agarose (Qiagen) prewashed with GuHCl. The 
samples were incubated over night at 4°C followed by centrifugation (4000rpm,  
10min, 4°C). Sedimented agarose was washed once with buffer A (8M urea, 0.1M 
Na2HPO4, 0.1M NaH2PO4, 10mM Tris/HCl pH 8.0, 20mM imidazole and 5mM 
βmercaptoethanol) and two times with buffer B (8M urea, 0.1M Na2HPO4, 0.1M 
NaH2PO4, 10mM Tris/HCl pH 6.3, 20mM imidazole and 5mM β -mercaptoethanol).  
6His-Ubiquitin conjugates were eluted from the Ni-NTA agarose with 30µl Nickel 
resin elution buffer (200mM imidazole, 5% (w/v) SDS, 150mM Tris/HCl (pH 6.7), 
30% (v/v) glycerol, 720mM β-mercaptoethanol, 0.01% (w/v) bromophenol blue).   
After denaturation, proteins were separated by SDS-PAGE, transferred to 
nitrocellulose blotting membranes (0.45µm) and visualized by immunoblotting.  
Autoradiograms were scanned and cropped using Adobe Photoshop CS6 and 
Figures were prepared using Adobe Illustrator CS6 software.  
  
Ubiquitinylation Assay. Cells transfected were treated with 10µM MG132 and  
25mM NEM for 4h before harvesting to inhibit proteasome and protease function. 
Lysis was performed in 1% SDS lysis buffer (150mM NaCl; 25mM Hepes (pH 7.5);  
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0.2% NP-40; 1mM Glycerol; 10mM NaF; 8mM ß-Glycerophosphat; 1mM DTT; 300μM 
Sodium-vanadate; complete protease inhibitor and 1% SDS). For 
immunprecipitation lysates were immunoprecipitated with Daxx Ab, followed by 
immunblotting with -Daxx and -Ubiquitin Ab.   
  
Indirect immunofluorescence. For indirect immunofluorescence H1299 cells were 
grown on glass coverslips in 1.5x10E5 cells per well. At different times cells were 
fixed in 4% paraformaldehyd (PFA) for 20min at 4°C or with ice-cold ethanol for 
10min at -20°C. Subsequently cells were permeabilized in PBS with 0.5 Triton X-100 
for 5min at room temperature. After 15min blocking in tris-buffered saline-BG 
(TBSBG; BG is 5% (wt/vol) BSA and 5% (wt/vol) glycine) buffer coverslips were 
treated for 30min with the indicated primary antibody diluted in PBS, washed three 
times in  
TBS-BG. After 20min incubation with the corresponding Alexa 488 (Invitrogen)- or 
Cy3 (Dianova)-conjugated secondary antibodies they were washed two times in  
TBS-BG and one time in PBS. The coverslips were then mounted in Glow medium 
(Energene) and digital images were acquired with a confocal laser scanning 
microscope (Nikon). Images were sampled to Nyquist and analyzed using Fiji (40).   
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Results   
HAdV infection sequesters RNF4 STUbL into the insoluble matrix fraction of the 
host cell nucleus. Since host DNA damage repair (DDR) impedes viability and 
propagation of DNA viruses, HAdV efficiently target a multitude of host cell DDR 
repair regulatory factors such as Mre11 and SPOC1 in order to promote productive 
infection (42). RNF4 plays a critical role in the cellular response to DNA double 
strand breakes (DSB), prompting us to examine RNF4 protein levels in low-salt RIPA 
extracts from infected human cells (Fig. 1A, left panel). We observed that RNF4 levels 
are reproducibly reduced in soluble extracts 48h post wild type infection (H5pg4100). 
Moreover, we confirmed that Mre11 protein levels are also significantly decreased 
during HAdV infection. This protein is a component of the MRN repair complex and 
represents a classical target of the adenoviral E3 Ubiquitin ligase complex containing 
E1B-55K, E4orf6 and additional host determinants (5, 8, 10, 4345). In parallel, we also 
observed that the PML-NB associated Daxx protein levels are decreased during 
HAdV infection. This is consistent with earlier findings demonstrating that 
SUMOylated E1B-55K binds and sequesteres Daxx into the proteasomal pathway of 
the cell by a mechanism still not understood in detail (8). We note that the Daxx 
antibody also detects a higher migrating unspecific band, which we refer to as 
unspecific (see Fig. 5F).   
Next, we tested RNF4 levels in mutant virus infected cells, which do not express viral 
E1B-55K (H5pm4149) (Fig. 1A, right panel). We observed that without E1B-55K 
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present, Daxx level is not reduced, and RNF4 protein level is much less reduced 
compared to wild type infected cells. As expected, also Mre11 is not affected in 
E1B55K lacking infected cells due to a non-functional E1B-55K/E4orf6 E3 Ubiquitin 
ligase complex.  
Simultanously, we determined RNF4 localization during HAdV wt (H5pg4100) 
infection. Intriguingly, we discovered that RNF4 is still detectable, and thus not 
degraded 48h post infection (Fig. 1B, panel f). We even found this host STUbL 
juxtaposed to a specific E1B-55K fraction in round-shaped aggregates within 
nonDAPI stained regions in the nucleus (Fig. 1B, panel h, i), presumably 
representing the insoluble fraction of the infected cell. These results show that RNF4 
was efficiently removed from the soluble fraction during the course of HAdV 
infection and relocalized adjacent to E1B-55K-containing aggregates in the host 
nucleus.  
To verify this observation, we next performed subcellular fractionation of infected 
cells at eight and 72h post infection, subjected these extracts to western blot and 
analyzed with antibodies directed against RNF4 and E1B-55K. In addition, we 
included antibodies that recognize human Histone 3 as a control for the nuclear 
fraction (Fig. 1C). In accordance with previous observations (2), E1B-55K was found 
in all cell fractions 72h post infection (Fig. 1C, lanes 3, 6, 7, 9). However, the larger 
SUMOylated moieties of the viral protein were mainly observed in the insoluble 
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matrix fraction of the infected cell at 48h post infection (Fig. 1C, right panel, lane 9). 
As expected, we detected RNF4 in cytoplasmic and soluble nuclear fractions at time 
zero (Fig. 1C, left panel, lanes 1, 4); however the subcellular RNF4 distribution was 
clearly perturbed during HAdV infection. By 72h post infection, this cellular STUbL 
was completely sequestered into the insoluble matrix fraction (F5; Fig. 1C, left panel, 
lane 6). An additional comparison with H5pm4149 infected cells, not expressing 
E1B55K, showed that relocalization of RNF4 into the nuclear matrix fraction is E1B-
55K dependent, as the majority of RNF4 was detected in the cytoplasm fraction 72h 
post H5pm4149 infection (Fig. 1C, right panel, lanes 8 and 10) compared to wild type 
infection (H5pg4100).   
Additionally, we tested the intracellular Daxx distribution since this PML-NB 
component and anti-HAdV factor is sequestered into the host proteasomal 
degradation pathway during infection. Previously, we found that this process solely 
depends on the presence of SUMO conjugated E1B-55K (46). Here, Daxx is mainly 
detectable in the nuclear matrix fraction; however 72h post infection, Daxx showed 
an additional band with higher molecular weight pointing to significant PTM 
accompanied by a severe reduction in protein levels (Fig. 1C, left panel, lanes 6).    
Hence, taken together our immunofluorescence data and fractionation assay results 
reveal that E1B-55K localizes juxtaposed to the host STUbL RNF4 in the insoluble 
fraction of the infected cell. In parallel, we observed reduced Daxx protein levels in 
the same insoluble fraction during HAdV infection only when E1B-55K is expressed.   
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HAdV E1B-55K protein is a novel interaction partner of the host STUbL RNF4. 
Given the above results, we further investigated intracellular localization of E1B-55K 
and RNF4 in transient transfection experiments. Consistent with previous results, 
immunofluorescence analyses in E1B-55K-transfected human cells revealed that this 
viral protein mostly concentrates in perinuclear bodies 48h post transfection and 
infection (2, 47). In contrast to the mostly diffuse nuclear localization 24h post 
transfection (Fig. 2A, panel f), by 48h post transfection, RNF4 in the transiently 
transfected cells was completely sequestered into the E1B-55K-containing aggregates 
(Fig. 2A, panel l).   
Since we observed recruitment of RNF4 with E1B-55K and the SUMOylated E1B-55K 
into the insoluble matrix fraction during infection, we next tested whether E1B-55K 
interacts with the endogenous RNF4 protein fraction in infected cells. As anticipated, 
in wt (H5pg4100) infected cells, E1B-55K coimmunoprecipitated with RNF4-specific 
antibody, revealing an interaction between both factors (Fig. 2B, lane 6). No E1B-55K 
signal was observed in the corresponding negative controls (Fig. 2B, lane 5).  
Agreeing with the data obtained in infected cells, we also detected RNF4 binding to 
E1B-55K in the absence of any viral background (Fig. 2B, lane 8).   
Next, we investigated the impact of E1B-55K SUMOylation on the protein interaction 
with the host STUbL protein RNF4. Therefore, we coexpressed RNF4 with E1B-55K 
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wt and the SUMO-deficient mutant K104R/SCS (Fig. 2C). To control our findings, 
we also included the NES mutant of E1B-55K, which is even more efficiently SUMO 
modified (Fig. 2A, panels g and k; 48, 49-54) than the wt protein. Our results show 
that loss of SUMO conjugation in pE1B-55K-SCS transfected human cells does not 
significantly impact on the binding ability between the viral factor and RNF4.    
Together these data show that HAdV induces an altered localization of the host  
STUbL protein into specific insoluble E1B-55K-containing aggregates and that 
E1B55K SUMOylation does not abrogate binding of the viral factor to RNF4.  
  
HAdV E1B-55K interaction with RNF4 is NLS-, SIM- and ARM-independent. To 
test whether the putative RNF4 nuclear localization sequence (NLS) domain is 
involved in the E1B-55K-mediated relocalization of RNF4 into perinuclear 
aggregates, RNF4 variants with mutated NLS signals were generated. Intracellular 
fluorescence analyses revealed that E1B-55K-mediated relocalization of RNF4 is 
independent of the putative NLS in the STUbL protein, since Flag-RNF4-RTR version 
with mutated NLS signals was sequestered into the E1B-55K-containing aggregates 
in the presence of the viral protein (Fig. 3A, panel k and l). Our quantitation revealed 
that the E1B-55K protein was approximately 40% more efficient in relocalizing the 
RTR mutant of RNF4 into perinuclear body aggregates. Similarly, a mutant with a 
severe defect in Ubiquitin modification of the STUbL protein itself (Flag-RNF4-K5R) 
did not affect E1B-55K-mediated relocalization of RNF4 (Fig. 3A, panel p and q).  
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RNF4 contains tandem SUMO-interacting motifs (SIM), which have specific 
consensus sequences to interact with SUMO or SUMO-like domains of their 
ubiquitinylation targets (33). Besides the SIM, a conserved arginine-rich motif (ARM) 
acts as a novel recognition motif in RNF4 for selective target recruitment. Results 
obtained by intracellular fluorescence analyses showed that both factors still 
colocalize in the host nucleus as well as in perinuclear aggregates despite the SIM or 
ARM mutations in RNF4 (Fig. 3B, panel b,c and g, h and l, m). Although, quantitation 
analyses show no change in R-values for RNF4 colocalization with E1B55K between 
wild type and SIM/ARM mutants, we observe differences in intracellular 
distributions of the protein complex. RNF4-SIM/E1B-55K complexes are distributed 
in accordance to RNF4-WT/E1B-55K complexes within perinuclear bodies and 
nucleus. Interestingly, this changes when the ARM region of RNF 4 is altered, as 
RNF4 shows additional cytoplasmic localization in E1B-55K transfected cells (Fig. 
3B, panels g and l), indicating that E1B-55K mediated relocalization into the nuclear 
matrix is not as efficient as with wild type RNF4 protein.   
To investigate, whether the NLS, SIM, ARM or defective Ubiquitin modification 
mutations in RNF4 affect binding to E1B-55K, we performed additional 
coimmunoprecipitation studies. As anticipated, in E1B-55K-transfected human cells, 
E1B-55K coimmunoprecipitated with RNF4-specific antibody, confirming the 
interaction between both factors (Fig. 3C, lane 11-18), while no E1B-55K signal was 
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observed in the corresponding negative controls (Fig. 3C, lane 10). We observed only 
a minor reduction in E1B-55K-binding to RNF4 without a functional SIM domain  
(Fig. 3C, lanes 12), and therefore conclude that the viral protein is not recruited via a  
SIM-dependent mechanism as shown for other SUMOylated targets of RNF4.  The 
ARM region does not affect the RNF4 SIM-independent binding to E1B-55K; 
however reduced binding was observed with the NLS mutant Flag-RNF4-RTR (Fig. 
3C, lane 18). However, Flag-RNF4-RTR still colocalized with E1B-55K, supporting 
the fact that reduced binding is sufficient for both proteins to localize together in 
perinuclear bodies and in the nucleus.  
    
HAdV infection promotes RNF4 interaction with Daxx during infection. Next, we 
asked whether RNF4 binding to E1B-55K interferes with the viral factor’s association 
with already known interaction partners such as the PML-NB-associated HAdV 
restriction factor Daxx. Since we had already observed intracellular localization of 
Daxx within the nuclear matrix fraction together with RNF4 and E1B-55K above, we 
examined the binding between RNF4 and Daxx at different times post infection (Fig. 
4A). We cotransfected HA-tagged Daxx and superinfected with HAdV wt virus (Fig.  
4A). Our results indicate that Daxx does not show RNF4 binding in uninfected cells 
(Fig. 4A, lane 4). However, with ongoing increase of E1B-55K protein expression 
during infection (Fig. 4A, lane 1-3), we clearly detect an interaction between Daxx 
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and RNF4 (Fig. 4A, lane 6). This supports the notion that HAdV infection and the 
presence of E1B-55K promotes binding between RNF4 and Daxx.  
  
E1B-55K promotes RNF4 dependent Daxx modification with Ubiquitin moieties.  
Since our results imply that E1B-55K connects Daxx and the SUMO-dependent 
Ubiquitin ligase RNF4 during infection, we tested whether Daxx PTM and protein 
stability are also affected. First, cells were transfected with different combinations of 
Daxx, E1B-55K and RNF4 expression plasmids. Under proteasome inhibition, 
immunoprecipitation of Daxx showed significant Daxx modification exclusively 
when both proteins, E1B-55K and RNF4, are present (Fig. 4B, lane 20). These 
experiments substantiate the possibility that SUMOylated E1B-55K recruits Daxx 
and connects it to RNF4 to promote Daxx PTM and most presumably proteasomal 
degradation of this anti-HAdV transcription factor.     
To further investigate this novel virus/host crosstalk, we transfected cells with 
Ubiquitin-His expression constructs and different combinations of Daxx, E1B-55K 
and RNF4 plasmids. Cells were not treated with proteasome inhibitors prior to 
harvesting and lysate preparation. Ni-NTA purification of Ubiquitin-His conjugates 
revealed that the fraction of modified Daxx protein was already reduced by 
proteasomal degradation when E1B-55K and RNF4 were present (Fig. 4C, lane 12). 
We also observe that E1B-55K alone reduced the Daxx signal (Fig. 4C, lane 11) 
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compared to Daxx levels in RNF4 expressing cells (Fig. 4C, lane 10). Intriguingly, in 
cells coexpressing RNF4 together with E1B-55K-SCS, the SUMOylation deficient 
variant of the viral protein (Fig. 4C, lane 14), we observed no change in 
immunoprecipitated Daxx protein fraction. This is consistent with earlier results 
showing that E1B-55K-SCS does not promote Daxx degradation (2, 11, 47).   
  
RNF4 fosters E1B-55K-mediated Daxx inhibition hence enhancing HAdV gene 
expression. Daxx is involved in transcriptional regulation and cellular intrinsic 
antiviral resistance against HAdV, as confirmed by earlier results where knockdown 
of Daxx using RNAi techniques significantly increased adenoviral replication, 
including enhanced viral mRNA synthesis and viral protein expression (55-57).  
However, early protein E1B-55K counteracts this Daxx restriction imposed upon 
HAdV growth by binding and degrading Daxx through a proteasome-dependent 
pathway. To investigate whether RNF4 promotes this E1B-55K-mediated inhibition 
of Daxx’ antiviral capacity, experiments were performed in human cells expressing 
shRNAs depleting RNF4. Reduced RNF4 RNA expression and protein sythesis was 
confirmed by real-time PCR analysis (Fig. 5A) and immunoblots (Fig. 5B). Reduction 
of RNF4 expression did not affect cell proliferation within the timeframe of six days 
post infection (Fig. 5C). To see the effect of RNF4 depletion on the virus life cycle, we 
assessed viral mRNA synthesis (Fig. 5D). HAdV transcription is promoted by RNF4 
expression in infected cells, since viral early E1A mRNA production was lower in 
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RNF4 depleted cells than in control cells (Fig. 5D, left panel). Similar results were 
obtained for Hexon mRNA expression, suggesting either a positive impact of the 
host STUbL on early gene products, or direct activation of the viral promoter (Fig. 
5D, right panel). To substantiate our results, data from the replication assays suggest 
that RNF4 expression also supports virus progeny production, since less virus 
particles were synthesized in the RNF4-depleted cell culture system after 48 and 72h 
post infection (Fig. 5E). Interestingly, steady-state concentrations of Daxx protein 
levels were more efficiently reduced in infected cells expressing RNF4 compared to 
shRNF4 cells. Our quantification shows that 48h post infection a 3.3-fold difference 
in Daxx protein levels was observed, which increases up to 40-fold after 72h. These 
data support the idea that RNF4 contributes to proteasomal Daxx degradation (Fig. 
5F, upper panel left). As the Daxx antibody detects various proteins bands, we 
additionally tested protein signal in cells stably depleted for Daxx expression. These 
data show that the antibody detects also an additional signal, which is not Daxx 
specific (Fig. 5F, lower panel, black asteriks). In sum, these observations substantiate 
our data showing a delayed Daxx reduction in shRNF4 cells (Fig. 5F, upper panel). 
Taken together, these results indicate that Daxx-mediated negative regulation of 
HAdV replication is counteracted by E1B-55K together with the host STUbL RNF4.  
Earlier, we reported that HAdV virus progeny production was promoted by loss of 
Daxx expression in Daxx depleted cells (21). To further clarify, whether RNF4 
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increases HAdV virus yield by Daxx inhibition, we transiently coexpressed shDaxx 
constructs in RNF depleted stable cell lines. We reproduced findings showing that 
shDaxx expression enhances virus yield almost two fold (Fig. 5G, lane 2) compared 
to parental cells (Fig. 5G, lane 1). As seen above, stable depletion of RNF4 reduced 
efficient virus production (Fig. 5G, lane 3). However, this was restored, when 
simultanously the shDaxx plasmid was expressed (Fig. 5G, lane 4).   
During infection it was shown that PML-NBs are relocalized by viral early proteins 
into track-like structures, juxtaposed to adenoviral replication centers. The question 
was whether such viral replication centers and PML-NBs are affected in cells 
depleted for RNF4. Intracellular immunofluorescence analysis revealed no 
significant difference in PML track formation in the absence of the host STUbL 
protein (Fig. 6A, panels h, j, k and l). However, detection of the viral marker protein 
E2A/DBP (red) intriguingly showed that compared with control cells expressing the 
scrambled shRNA (Fig. 6A, panels c, e and f), replication centers are not properly 
established in cells lacking RNF4 (Fig. 6A, panels i, k and l). Quantitative analysis 
showed a more diffuse staining of E2A/DBP within RNF4 depleted cells, whereas in 
parental cells E2A/DBP staining in replication centers were properly established 
(Fig. 6A, graph).  
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Discussion   
Here, we provide evidence that the cellular STUbL RNF4 aids HAdV E1B-
55Kdependent Daxx restriction during adenoviral infection. Thus, RNF4 is a novel 
host factor that significantly promotes HAdV infection by helping to mitigate the 
Daxxmediated antiviral host response. We demonstrate that expression of viral E1B-
55K promotes relocalization of RNF4 into the nuclear matrix fraction of the cell. 
These data supports our hypothesis that the host STUbL protein encounters Daxx to 
inhibit antiviral functions of this transcription factor.   
SUMO conjugation of target substrates is a crucial signaling event that regulates 
diverse processes in the mammalian cell, such as stress response, chromosome 
segregation, DNA-damage response and meiosis (21). Viruses have also evolved 
pathways to benefit from these PTM in order to create an efficient replication milieu 
in the host cell (58). In both scenarios recognition of SUMOylated proteins is mostly 
mediated through SIMs present on effector proteins (4). The discovery of STUbLs 
directly links the SUMOylation process to ubiquitinylation, and thus degradation 
pathways. Through tandem SIMs, STUbLs recognize poly-SUMOylated proteins 
and target them for Lys48-linked polyubiquitinylation and degradation through 
their E3 Ubiquitin ligase activities. So far, only two cellular STUbLs have been 
identified in mammalian cells, such as RNF111/Arkadia (59) and RNF4/SNURF 
(60). RNF4 is a dimeric STUbL with four functional SIMs in the protein that recognize 
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polySUMOylated substrates. The RING domain at the C-terminal part acts together 
with the SIM domains to facilitate ubiquitinylation of substrates already modified 
with poly-SUMO chains (61).   
HAdV have acquired mechanisms that modulate SUMO- and Ubiquitin-mediated 
regulatory cascades leading to efficient viral propagation (61, 62). During the course 
of productive infection, HAdV gene products manipulate destruction pathways to 
prevent viral clearance or cell death prior to viral genome amplification and release 
of progeny. We recently demonstrated that chromatin formation by cellular 
SWI/SNF chromatin-remodeling, involving Daxx/ATRX-dependent processes, 
plays a key role in HAdV transcriptional regulation and virus-mediated 
transformation (3, 4). Daxx and ATRX are SUMO substrates in the cell and 
transiently found associated with PML nuclear bodies, large multiprotein complexes 
representing SUMOylation hotspots in the host-cell nucleus. Our recent reports 
demonstrate the importance of Daxx/ATRX chromatin-remodeling activities for 
efficient HAdV gene expression; we showed evidence that HAdV promoters are 
affected by Daxx/ATRX recruitment, leading to a significant block in viral gene 
expression and progeny production (2, 21, 47).   
Early viral gene derepression mediated by incoming capsid protein VI (2, 21, 47) 
prior to E1B-55K/E4orf6-dependent restriction of Daxx/ATRX functional complexes 
is necessary for adenoviruses to evade antiviral host cell measures evolved to repress 
viral gene expression (summarized in Fig. 6B). In detail, based on our reported data,  
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HAdV-mediated protein degradation apparently discriminates between classical  
E1B-55K/E4orf6-dependent (ATRX) pathways and a novel E1B-55K-dependent 
(Daxx) degradation route. However, it is still unclear how Daxx degradation works 
mechanistically, and whether this is a kinetic process due to the expression pattern 
or PTM of the viral protein E1B-55K itself early during HAdV infection.  
RNF4 controls protein stability by ubiquitinylation of target substrates, such as PML 
or the oncogenic fusion protein PML-RAR (1, 63). Thus, the PML-associated factor 
Daxx, which interacts with the viral E1B-55K protein, might represent a novel STUbL 
substrate. RNF4 relies on its SIM domains to selectively bind poly-SUMO chains over 
monomer SUMO. For instance, only poly-SUMOylated PML proteins are recognized 
by RNF4 (61, 64). Here, we observe that neither RNF4 SIMs nor the ARM region is 
essential for the cellular STUbL to bind to E1B-55K. Perhaps substrate SUMOylation 
provides additional binding sites that facilitate protein ubiquitinylation and 
degradation by the RING domain of RNF4 protein.   
Besides the mammalian STUbLs RNF4 and RNF111 (Arkadia), additional viral 
STUbLs such as VZV ORF61, KSHV K-Rta and HSV ICP0 (64) have been described 
so far. ICP0 functions as a STUbL that preferentially ubiquitinylates 
polySUMOylated PML during HSV infection as a mechanism to inhibit the antiviral 
activities of PML. Notably, ICP0 represents the first precise viral ortholog of the host 
STUbL RNF4 to target cellular proteins such as PML and associated factors (65-67).  
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Although it lacks the canonical RING domain, work by Bridges and coworkers 
suggest that the adenoviral E4orf3 might possess STUbL-like functions or recruit 
cellular STUbLs to regulate cellular protein stability by SUMO-mediated, 
Ubiquitindependent degradation (68). . Also HTLV-1 oncoprotein Tax is a substrate 
for RNF4. Upon RNF4-dependent ubiquitinylation, Tax is relocalized into the 
cytoplasm to activate the NF-kB pathway by direct interaction between Tax and 
NEMO (69). These findings provide important new insights into STUbL-mediated 
pathways that regulate the subcellular localization and functional dynamics of viral 
oncogenes .  
In addition, RNF4 blocks EBV infection by ubiquitinylation of the transcription factor 
Rta, which is required to activate the transcription of EBV lytic genes. Upon 
ubiquitinylation, Rta is degraded and subsequently EBV lytic replication and virion 
production is inhibited (70). Here, we find that RNF4 is a positive regulator of HAdV 
lytic infection, since together with E1B-55K it supports Daxx inhibition.   
Chromatin-modifying complexes containing Daxx have also been implicated in 
human cancer development. Evidence is growing for a correlation between 
chromatin-modifiers and tumor suppression, especially demonstrated for SWI/SNF 
complexes, which comprise several subunits displaying tumor suppressor activity. 
Functional disruption of SWI/SNF complexes may induce a state of epigenetic 
instability, resulting in altered chromatin structure that affects gene expression, and 
interferes with differentiation processes. These epigenetic changes may be closely 
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linked to genomic instability, and predispose to oncogenic transformation (71). 
Indeed, we recently reported that efficient adenoviral transformation requires 
E1B55K-mediated degradation of Daxx (47). In accordance with our current study, 
we envisage that RNF4 could contribute to cell transformation by modulating 
Daxxdependent pathways in cooperation with E1B-55K, and consequently through 
disrupting SWI/SNF chromatin-remodeling functions. This is a particularly 
interesting concept given the oncogenic capabilities of certain STUbLs, which have 
shown to cooperate with either Daxx or associated determinants.   
Further elucidating the crosstalk between the cellular and viral regulators discussed 
above will help us better understand the role of chromatin-remodeling in HAdV 
transcriptional regulation and adenoviral transformation of primary cells. Moreover,  
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543 further investigation of STUbLs during virus infection will help to identify novel 544 
therapeutic approaches to modern antiviral therapy and inhibitor development.   
545  
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799 Tables and Figure Legends   
800  Tab 1. Overview Oligonucleotides.  
  
Primer no.  
  
Primer description  Primer sequence  
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18S rRNA fw  
  
5’- CGGCTACCACATCCAAGGAA -3’  
1372  18S rRNA rev  5’- GCTGGAATTACCGCGGCT -3’  
1441 Hexo fw  5’- CGCTGGACATGACTTTTGAG -3’  
1442 Hexon rev  5’- GAACGGTGTGCGCAGGTA -3’  
1686 E1A fwd  5’- GTG CCC CAT TAA ACC AGT TG -3’  
1687 E1A rev  5’- GGC GTT TAC AGC TCA AGT CC -3’  
3356 RNF4 fwd  5’-GGTGGAGCAATAAATTCTAGACAAGC-3’  
3357 RNF4 rev   5’-CCACCACAGGCTCTAAAGATTCACAAGTGAGG-3’  
2978 RNF4 RTR fwd  5’- CAAGCTCAGAAGGCAGCGGCGGAAGCAACCTCC -
3’  
2979 RNF4 RTR rev  5’- GGAGGTTGCTTCCGCCGCTGCCTTCTGAGCTTG -3’  
3070 RNF4 K5R fwd  5’- GCTCCATGAGTACAGGAAAGCGTCGTGG -3’  
3071 RNF4 K5R rev  5’- CCACGACGCTTTCCTGTACTCATGGAGC -3’  
    
 
801    
802    
803    
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804 Fig. 1. HAdV mediated modulation of RNF4 protein during infection. (A) H1299  
805 cells were infected with either wt virus (H5pg4100, left panel) or with an E1B-55K  
806 null mutant (H5pm4149, right panel) at a multiplicity of 50FFU per cell and  
807 harvested after indicated time points post infection. Total-cell extracts were prepared  
808 with low salt RIPA buffer, separated by SDS-PAGE and subjected to  
809 immunoblotting using RNF4 mouse mAb (kindly provided by Takeshi Urano), Daxx  
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rabbit pAb 07-471 (Upstate), mouse mAb 2A6 ( -E1B-55K), E4orf6 mouse mAb RSA3, 809 
HAdV-5 rabbit polyclonal serum L133, Mre11 rabbit pAb pNB 100-142 (Novus 810 
Biologicals, Inc.), rabbit mAb -E2A ( -E2A/DBP) and mAb AC-15 (anti-β-actin) as 811 
a loading control. Molecular weights in kDa are indicated on the left, relevant 812 
proteins on the right. (B) H1299 cells transfected with 2µg pFlag-RNF4-WT and 813 
infected with wt virus (H5pg4100) at a multiplicity of 20FFU per cell and fixed with  814 
4% PFA after 48 h post infection. Cells were labeled with anti-Flag mouse mAb M2  815 
(Sigma-Aldrich, Inc.), detected with Alexa488 ( -Flag; green) and mouse mAb 2A6 816 
( -E1B-55K), detected with Cy3 ( -E1B-55K; red) conjugated secondary antibody. 817 
Nuclei are labeled with DAPI (4,6-diamidino-2-phenylindole). Representative -Flag 818 
(green; Bb, Bf), -E1B-55K (red; Bc, Bg), DAPI (blue; Ba, Be) staining patterns, overlay 819 
of the single images (merge; Bd, Bh) and enlarged overlay (merge; Bi) are shown 820 
(magnification x 7600). (C) H1299 cells were infected with wt virus (H5pg4100, left 821 
and right panel) or an E1B-55K null mutant (H5pm4149, right panel) at a multiplicity 822 
of 50FFU per cell and harvested after indicated time points post infection (left panel) 823 
or after 48h (right panel). Cell extracts were fractionated into cytoplasm and insoluble 824 
nuclear factions. Equivalent amounts of protein for each fraction were separated by 825 
SDS-PAGE and subjected to immunoblotting using the Ab indicated in (A) plus 826 
rabbit mAb H3 ( -Histone 3). Molecular weights in kDa are indicated on the left, 827 
relevant proteins on the right.  828 
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  829 
Fig. 2. E1B-55K interaction with RNF4 protein. (A) H1299 cells were cotransfected 830 
with 2µg pFlag-RNF4-WT and 2µg pE1B-55K. After 24 and 48h post transfection, cells 831 
were fixed with 4% PFA and labeled with -Flag mouse mAb M2 (SigmaAldrich, 832 
Inc.), detected with Alexa488 ( -Flag; green) and mouse mAb 2A6 ( -E1B55K), 833 
detected with Cy3 ( -E1B-55K; red) conjugated secondary antibody. Mock cells are 834 
transfected but not infected. Nuclei are labeled with DAPI (4,6-diamidino-835 
2phenylindole). Representative -Flag (green; Db. Df, Dj), -E1B-55K (red; Dc, Dg,  836 
Dk), DAPI (blue; Da, De, Di) staining patterns and overlays of the single images 837 
(merge; Dd, Dh, Dl) are shown (magnification x 7600). (B) H1299 cells were 838 
transfected with an empty vector control or a plasmid encoding E1B-55K and 839 
harvested 48h post transfection, or were infected with wt virus (H5pg4100) at a 840 
multiplicity of 50FFU per cell, harvested 24h post infection and total-cell extracts 841 
were prepared. Immunoprecipitation of endogenous RNF4 was performed using 842 
RNF4 mouse pAb A01 (Abnova), proteins were separated by SDS-PAGE and 843 
subjected to immunoblotting. Input levels of total-cell lysates and coprecipitated 844 
proteins were detected using mouse mAb 2A6 ( -E1B-55K), RNF4 mouse pAb A01 845 
(Abnova) and mouse mAb AC-15 ( -β-actin) as a loading control. Note that heavy 846 
chains (IgH) are detected at 55 kDa. Molecular weights in kDa are indicated on the 847 
left, relevant proteins on the right. (C) H1299 cells were cotransfected with 5µg pFlag-848 
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RNF4-WT and 3µg pE1B-55K-wt, 6µg SCS (SUMO-conjugation site K104R mutant) or 849 
1.5µg NES (nuclear-export-signal mutant) and harvested 48h post transfection and 850 
total-cell extracts were prepared. Immunoprecipitation of pFlagRNF4 was performed 851 
using -Flag mouse mAb M2 (Sigma-Aldrich, Inc.), proteins were separated by SDS-852 
PAGE and subjected to immunoblotting. Input levels of total-cell lysates and 853 
coprecipitated proteins were detected using the Ab indicated in (B) Molecular 854 
weights in kDa are indicated on the left, relevant proteins on the right.  855 
  856 
Fig. 3. E1B-55K binding is mediated by several regions in the RNF4 protein. (A)  857 
H1299 cells were cotransfected with 2µg of pE1B-55K and 2µg pFlag-empty, 858 
pFlagRNF4-WT, RTR or K5R. Cells were fixed with 4% PFA after 48h post 859 
transfection  and labeled with -Flag mouse mAb M2 (Sigma-Aldrich, Inc.), detected 860 
with Alexa488 ( -Flag; green) conjugated secondary antibody. Representative -Flag 861 
(green; Bb, Bf, Bk, Bp), -E1B-55K (red; Bc, Bg, Bl, Bq), DAPI (blue; Ba, Be, Bj, Bo) 862 
staining patterns, overlays of the single images (merge; Bd, Bh, Bm, Br) and 2D 863 
intensity histogramms (Bi, Bn, Bs) are shown (n=50 cells). Schematic representation 864 
of pFlag-RNF4-WT, the pFlag-RNF4-RTR (3 aa mutation in the putative NLS signal 865 
K192021R) and pFlag-RNF4-K5R construct (1 aa mutation in the putative 866 
ubiquitinylation site). Mutated regions were marked in red. (B) H1299 cells were 867 
cotransfected with 2µg of pE1B-55K and 2µg pFlag-RNF4-SIM, ARM or SIM/ARM.  868 
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Cells were fixed with 4% PFA after 48h post transfection and labeled at indicated in  869 
(A). Representative -Flag (green; Cb, Cg, Cl), -E1B-55K (red; Cc, Ch, Cm), DAPI 870 
(blue; Ca, Cf, Ck) staining patterns, overlays of the single images (merge; Cd, Ci, Cn) 871 
and 2D intensity histogramms (Ce, Cj, Co) are shown (n=50 cells). Schematic 872 
representation of the mutated pFlag-RNF4 constructs SIM (deletion of SIM 1-4), ARM 873 
(deletion of ARM, position 73-83) and SIM/ARM (deletion of SIM 1-4 and  874 
ARM). Mutated regions were marked in red. Colocalization of Flag-RNF4 and 875 
E1B55K was analyzed using coloc2 in Fiji (47) and calculated using Pearson’s 876 
correlation coefficient (R-Value). (C) H1299 cells were cotransfected with a plasmid 877 
encoding E1B-55K and pFlag-RNF4-WT, SIM, ARM, SIM/ARM, K5R, K18R, K5/18R 878 
and RTR and harvested 48h post transfection and total-cell extracts were prepared. 879 
Immunoprecipitation of pFlag-RNF4 was performed using -Flag mouse mAb M2 880 
(Sigma-Aldrich, Inc.). Proteins were separated by SDS-PAGE and subjected to 881 
immunoblotting. Input levels of total-cell lysates and coprecipitated proteins were 882 
detected using mouse mAb 2A6 ( -E1B-55K), anti-Flag mouse mAb M2 883 
(SigmaAldrich, Inc.), and mouse mAb AC-15 ( -β-actin) as a loading control.  884 
Molecular weights in kDa are indicated on the left, relevant proteins on the right.  885 
  886 
Fig. 4. HAdV infection promotes RNF4/Daxx interaction and Daxx Ubiquitin PTM.  887 
(A) H1299 cells were infected with wt virus (H5pg4100) at a multiplicity of 50FFU per 888 
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cell (left panel) and cotransfected with 2µg of HA-Daxx prior to infection, harvested 889 
16 and 36h post infection and total-cell extracts were prepared.  890 
Immunoprecipitation of endogenous RNF4 was performed using RNF4 mouse pAb 891 
A01 (Abnova), proteins were separated by SDS-PAGE and subjected to  892 
immunoblotting. Input levels of total-cell lysates and coprecipitated proteins were 893 
detected using mouse mAb 2A6 ( -E1B-55K), RNF4 mouse pAb A01 (Abnova), Daxx 894 
rabbit pAb 07-471 (Upstate) and mouse mAb AC-15 ( -β-actin) as a loading control. 895 
Note that light chains (IgG) are detected at 20kDa. Molecular weights in kDa are 896 
indicated on the left, relevant proteins on the right.  897 
(B) H1299 cells stably were transfected with 5µg of pRNF4-Flag and pE1B-55K. 898 
Cells were treated with 25mM NEM and 10µM Mg132 and incubated for additional 899 
4h.  900 
28h post transfection, cell pellets were resuspended in 1% SDS lysis buffer and 901 
cleared by centrifugation. Modification of Daxx was analyzed by immunoblotting 902 
after SDS-PAGE. Input levels of total-cell lysates and immoprecipitated Daxx were 903 
detected using Daxx rabbit pAb 07-471 (Upstate), mAb P4D1 ( -Ubiquitin), RNF4 904 
mouse pAB A01 (Abnova) and mAb 2A6 ( -E1B-55K). Molecular weights in kDa 905 
are indicated on the left, relevant proteins on the right.  906 
(C) H1299 cells stably were transfected with 10µg pUbiquitin-His and 5µg each 907 
of pDaxx-HA, pRNF4-Flag and either pE1B-55K or pE1B-55K-SCM. Cells were 908 
treated with 25mM NEM and total-cell lysates were prepared with guanidinium 909 




  { PAGE   \* MERGEFORMAT }  
chloride buffer 28h post transfection, subjected to Ni-NTA purification of Ubiquitin-910 
His conjugated proteins. Proteins were separated by SDS-PAGE and subjected to 911 
immunoblotting. Input levels of total-cell lysates and Ni-NTA purified proteins were 912 
detected using Daxx rabbit pAb 07-471 (Upstate), mAb 6xHis ( -His), mAb AC-15 913 
( - -actin) and mAb 2A6 ( -E1B-55K). Molecular weights in kDa are indicated on 914 
the left, relevant proteins on the right.  915 
  916 
Fig. 5. RNF4 knock down reduces HAdV viral gene expression and progeny 917 
production. (A) H1299 shscrambled and H1299 shRNF4 cells were harvested and 918 
total RNA was extracted, reverse transcribed and quantified by RT-PCR analysis 919 
using primers specific for RNF4. The data were normalized to 18S rRNA levels. The 920 
data is presented as relative RNF4 mRNA levels, compared between H1299 shRNF4 921 
and control cells H1299 shscrambled. (B) Endogenous RNF4 protein levels in H1299 922 
shscrambled and H1299 shRNF4 cells were determined by preparing whole-cell 923 
extracts followed by SDS-PAGE and immunoblotting using RNF4 mouse mAb 924 
(kindly provided by Urano) and mouse mAb AC-15 ( -β-actin) as a loading control.  925 
Molecular weights in kDa are indicated on the left, relevant proteins on the right. (C) 926 
1x105 cells (H1299 shscrambled and H1299 shRNF4) were cultivated and absolute cell 927 
numbers were determined after the indicated time points. The mean and standard 928 
deviations are presented for three independent experiments. (D) H1299 shscrambled 929 
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and H1299 shRNF4 cells were infected with wt virus (H5pg4100) at a multiplicity of 930 
20FFU per cell. The cells were harvested 16 and 48h post infection, total RNA was 931 
extracted, reverse transcribed, and quantified by RT-PCR analysis using primers 932 
specific for HAdV-C5 E1A and Hexon. The data were normalized to 18S rRNA levels 933 
and the mean and standard deviations are presented for three independent 934 
experiments. (E) H1299 shscrambled and H1299 shRNF4 cells were infected with wt 935 
virus (H5pg4100) at a multiplicity of 50FFU per cell. Viral particles were harvested 48 936 
and 72h post transfection and virus yield was determined by quantitative E2A/DBP 937 
immunofluorescence staining on HEK293 cells. The mean and standard deviation are 938 
presented for three independent experiments. Values are shown as a ratio 939 
shscrambled/shRNF4. (F) H1299 shscrambled and H1299 shRNF4 cells were infected 940 
with wt virus (H5pg4100) at a multiplicity of 50FFU per cell and harvested after 941 
indicated time points post infection. Total-cell extracts were prepared, separated by 942 
SDS-PAGE and subjected to immunoblotting using RNF4 mouse mAb (kindly 943 
provided by Urano), Daxx rabbit pAb 07-471 (Upstate) and mAb AC-15 ( -βactin) as 944 
a loading control. Daxx and ß-actin blots were used for quantitative analysis and 945 
amount comparison for Daxx/ß-actin intensity ratio at 48 and 72h p.i.. HepaRG 946 
shDaxx cells were cotransfected with 5µg of Flag-Daxx (lower panel) harvested 24h 947 
post transfection and total-cell extracts were prepared. Proteins were separated by 948 
SDS-PAGE and subjected to immunoblotting. Input levels of total-cell lysates were 949 
detected using Daxx rabbit pAb 07-471 (Upstate) and mouse mAb AC-15 ( -β-actin) 950 




  { PAGE   \* MERGEFORMAT }  
as a loading control. Molecular weights in kDa are indicated on the left, relevant 951 
proteins on the right. (G) H1299 shscrambled and H1299 shRNF4 cells cotransfected 952 
with 5µg shDaxx construct and 24h later superinfected with wt virus (H5pg4100) at a 953 
multiplicity of 50FFU per cell. Viral particles were harvested 48h post transfection 954 
and virus yield was determined by quantitative E2A/DBP immunofluorescence 955 
staining on HEK293 cells. The mean and standard deviation are presented for three 956 
independent experiments.   957 
  958 
Fig. 6. RNF4 affects establishment of viral replication centers. (A) H1299 cells were 959 
infected with wt virus (H5pg4100) at a multiplicity of 20FFU per cell and fixed with 960 
methanol after 48h post infection. Cells were labeled with -PML pAb NB 100-59787 961 
(Novus Biologicals, Inc) and rabbit mAb -E2A/DBP, detected with Alexa488 962 
( PML; green) and Cy3 ( -E2A/DBP; red) conjugated secondary antibody. Nuclei 963 
are labeled with DAPI (4,6-diamidino-2-phenylindole). Overlay of images (merge; d, 964 
j) and corresponding enlarged overlay (merge; e, f) staining patterns are shown. 965 
E2A/DBP staining was quantified and analysed by counting the ratio between 966 
diffuse and replication center localization in infected cells. (B) Model of crosstalk 967 
between RNF4, Daxx and E1B-55K. Schematic representation illustrating a proposed 968 
model linking of E1B-55K dependent Daxx restriction and modulation by cellular 969 
factor RNF4. Upon HAdV infection, RNF4 is recruited to the nucleus in an E1B-55K- 970 
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971 dependent manner to promote Daxx PTM prior to proteasomal degradation to 972 
counteract the cellular chromatin complex and ensure efficient viral gene expression.  
  
  
  
 
  
  
  
  
  
  
  
 
